Belgium· BE-AMP-SAM077034-00
Myambutol 400 mg
A ethambutol product containing ethambutol dihydrochloride, registered in Belgium by Teofarma. The same ATC class is registered in 15 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Ethambutol is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AK02 (ethambutol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Ethambutol · ATC J04AK02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ethambutol costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), the median price runs from $0.24 in France to $4.44 in Switzerland — a ×18 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ethambutol · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.44
- FR France$0.24
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ethambutol Dihydrochloride
- Manufacturer
- Teofarma
- Country
- Belgium (BE)
- ATC code
- J04AK02
- ATC class
- Ethambutol
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb0058396EUR 31.11
- be_apb0712273
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
148 interactions on record for ethambutol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ethambutol · interactions on record
148 records
- 4 severe
- 78 moderate
- 65 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ethambutol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesEthambutol HydrochlorideSTI Pharma LLC
- NetherlandsMyambutol 400 mg filmomhulde tablettenMedcor Pharmaceuticals B.V.
- FinlandStambutolPharmacal Oy Ab
- SwitzerlandMyambutol 400mg, comprimés pelliculésLabatec Pharma SA
- IrelandEthambutol Hydrochloride 400mg film-coated tabletsAspire Pharma (Malta) Limited
- FranceMYAMBUTOL 400 mg, comprimé pelliculé sécableEFISCIENS (MALTE)
- CzechiaMYAMBUTOL
- United KingdomEMB-Fatol 1g/10ml concentrate for solution for infusion vialsImported (Germany)
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Etibi
- Bulgaria · Етамбутол Дс
- Germany · Emb-Fatol
- Spain · Myambutol
- Finland · Ethambutol Orion
- France · Dexambutol, Myambutol
- United Kingdom (Northern Ireland) · Ethambutol Brown & Burk Uk, Ethambutol Dawa
- Ireland · Ethambutol Hydrochloride Aspire Pharma (Malta)
- Italy · Etapiam, Miambutol
- Lithuania · Emb-Fatol
- Luxembourg · Myambutol
- Latvia · Amiobutols
- Netherlands · Myambutol
- Poland · Ethambutol Teva
- Portugal · Turresis
- Romania · Etambutol Arena, Etambutol Atb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd299790-324e-42a1-b54d-f1871db2ebc1 GET /v1/drugs/dd299790-324e-42a1-b54d-f1871db2ebc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Myambutol 400 mg",
"name_fr": "Myambutol 400 mg",
"name_nl": "Myambutol 400 mg",
"amp_code": "SAM077034-00",
"strengths": [
"400.0000",
"0.8200",
"16.0000",
"128.9200"
],
"pack_count": 1,
"substances": [
"Ethambutol Dihydrochloride",
"Sodium Laurilsulfate",
"Sorbitol",
"Sucrose"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Ethambutol",
"authorisation_numbers": [
"BE077034"
]
}See everything about ethambutol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.